Alnylam Pharmaceuticals
ALNY
#638
Rank
โ‚น2.686 T
Marketcap
โ‚น20,707
Share price
-0.59%
Change (1 day)
33.90%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: โ‚น2.686 Trillion

As of December 2024 Alnylam Pharmaceuticals has a market cap of โ‚น2.686 Trillion. This makes Alnylam Pharmaceuticals the world's 638th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น2.686 T34.36%
2023โ‚น1.999 T-17.35%
2022โ‚น2.419 T60.27%
2021โ‚น1.509 T36.7%
2020โ‚น1.104 T19.85%
2019โ‚น921.38 B78.63%
2018โ‚น515.80 B-35.88%
2017โ‚น804.49 B268.48%
2016โ‚น218.33 B-58.99%
2015โ‚น532.33 B12.16%
2014โ‚น474.61 B87.44%
2013โ‚น253.21 B382.76%
2012โ‚น52.45 B184.73%
2011โ‚น18.42 B-1.54%
2010โ‚น18.70 B-45.3%
2009โ‚น34.20 B-30.52%
2008โ‚น49.22 B5.79%
2007โ‚น46.53 B32.51%
2006โ‚น35.11 B202.91%
2005โ‚น11.59 B85.84%
2004โ‚น6.23 B

End of Day market cap according to different sources

On Dec 16th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

โ‚น2.670 Trillion
by Yahoo Finance info icon info icon
โ‚น2.670 Trillion
by CompaniesMarketCap info icon info icon
โ‚น2.670 Trillion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น236.24 B-91.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.820 T 153.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.027 T-61.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น91.36 B-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.11 B-99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น16.589 T 517.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น9.935 T 269.80%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1.587 T-40.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel